Re: Ortho Evra

From: Marie Harkins (mharkins@twcny.rr.com)
Tue Feb 28 06:57:01 2006


Larry,

Are you saying that the NuvaRing also has 2X RR VTE? I haven't seen this data yet. Has it been published? I wondered if it would have a similar profile of estrogen exposure as OrthoEvra .

Many women I have counseled about the new data on Ortho Evra have opted to continue with it anyway. Most are women who forget to take a daily OC and do not want the risk of pregnancy.

--
Marie Harkins, CNM
Ithaca, NY

On Monday, February 27, 2006, at 10:38 PM, Larry Glazerman wrote:

> I'm on Ortho's speaker's bureau. The bottom line is that despite the > new > info about a 60% higher average blood level with Evra than with OCs, > there > is NO data confirming an increased risk of any side effect. > > In conjunction with the FDA, Ortho has sponsored several epidemiologic > studies. One is now in press, and, to summarize, shows no difference > in VTE > between Evra and a 35 mcg pill. A second study, equally well done, not > yet > published, apparently shows an increase from 1-2/10,000 VTE with OC to > 2-4 > /10,000 with Evra. This is a RR of ~2, but an absolute risk of > 1-2/10,000 > patients (very low, IMHO). Also, it should be noted that other current > contraceptives have significant warnings in their package inserts: > > Seasonale - significantly higher bleeding rates > Yasmin - ?problems with K+ due to spironolactone like effect > NuvaRing - 2X RR VTE > > The fact remains that all of these hormonal contraceptives are very > safe, > probably none any safer or more dangerous significantly than any > other, and > ALL much safer than pregnancy!!!!!! > > Waiting for the flames :) > > Larry R. Glazerman, MD > > 610-402-0161 > l.glazerman@rcn.com > > -----Original Message----- > From: ob-gyn-l@obgyn.net [mailto:ob-gyn-l@obgyn.net] On Behalf Of > Garry E. > Siegel, M.D. > Sent: Monday, February 27, 2006 9:54 PM > To: Multiple recipients of list OB-GYN-L > Subject: Gyn: Ortho Evra > > The nice Ortho rep brought in a lunch today to talk about the bad rap > Evra has gotten, yet it is (according to him) the most prescribed > hormonal contraceptive in the US. > > Has anyone changed their habits regarding this since the poop has hit > the fan, i.e. the FDA made Ortho change the labeling and some brouhaha > about strokes? Has anyone seen the science on it? > > Garry > > -- > Garry E. Siegel, M.D. > Private Practice > Roswell, GA >





use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Fri May 2 04:43:46 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.